Librella destocking impact
Librella revenue decline will continue to pressure revenue in H1 FY27, with near-zero contribution in Q1 and Q2.
SYNGENEINTERNATIONAL / Q4-FY26 / risks
Keep the risk register visible.
Syngene International · Material risks, their source context, and severity in the latest available quarter.
Research layer active
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Material risks this quarter
high
Bay View facility cost drag
Bay View costs are only partially capitalized; full impact on P&L not yet known, potentially pressuring margins.
Geopolitical and tariff risks
Section 232 tariffs on pharma products could slow CDMO order flow, though management assesses negligible impact.
Margin trajectory uncertainty
Management cut margin guidance mid-year but beat it; path to high-20s margins remains unclear.